Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Methotrexate
×
Clear all
Filters
2
NCT02252042
2023-07-17
MK-3475-040
Merck Sharp & Dohme LLC
Phase 3
Completed
495 enrolled
32 charts